68 reports

  • RHEUMATOID ARTHRITIS

It causes chronic inflammation of any part or the entire gastrointestinal tract.

  • Arthritis
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.

CHAPTER VI MARKETING STRATEGIES ##.

  • Arthritis
  • China
  • Demand
  • Bayer AG
  • Yunnan Baiyao Group Co., Ltd.

THIS FURTHER ALLEVIATES PRURITUS, URTICARIA, ANGIOEDEMA AND RELIEVES GASTROINTESTINAL AND GENITOURINARY SYMPTOMS ASSOCIATED WITH ANAPHYLAXIS.

  • Arthritis
  • Neurological Disorder
  • World
  • Forecast
  • Antares Pharma, Inc.

Shanghai No. ## Biochemical Pharmaceutical Co., Ltd.

  • Arthritis
  • China
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • Market drivers

The key single-injection cycle products are ORTHOVISC, Genvisc ##, Gel-One, Hylan GF-##, and Synvisc-One.

  • Arthritis
  • Anika Therapeutics, Inc.
  • Ferring International Center S.A.
  • Sanofi S.A.
  • Seikagaku Corporation

Journal of Autoimmunity; ##(##): ##-##.

  • Arthritis
  • Japan
  • Spain
  • United States
  • Forecast
  • Opportunities for research in osteoarthritis
  • Vendor landscape

DONULIDE IS NOT RECOMMENDED FOR PATIENTS WITH GASTROINTESTINAL BLEEDING, ULCER, AND HYPERSENSITIVITY.

  • Arthritis
  • World
  • Ampio Pharmaceuticals, Inc.
  • Novartis AG
  • Pfizer Inc.

Table ##: The U. S.

  • Arthritis
  • United States
  • Anika Therapeutics, Inc.
  • Sanofi S.A.
  • Zimmer Biomet Holdings, Inc.

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation
  • THERAPEUTIC INTERVENTIONS FOR RHEUMATOID ARTHRITIS: MARKETED CORTICOSTEROIDS

DARWIN ## ##. ##. ##. ##. ##.

  • Arthritis
  • North America
  • United States
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • 18.2 Market Share Analysis 2014

Drivers and their Impact Impact on Key End-User Category Patients Driver Increase in Elderly Population High Prevalence of Osteoarthritis Unmet Medical Needs Growing Obese Population Hospitals Low Low ## ## ## ## ## High Low ## ## ## ## ## High Pharmaceutical Stores Low High ## ## ## ##

  • Arthritis
  • Abbott Laboratories, Inc.
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.

Rheumatoid arthritis

4385 5000 3900
  • PREVALENCE OF SELECTED CO-MORBIDITIES REPORTED IN THE INTERNATIONAL COMORA STUDY, BY REGION, 2014
  • RHEUMATOID ARTHRITIS PATIENTS RECEIVING TRADITIONAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY COUNTRY AND SEVERITY (%)

Side effects include gastrointestinal bleeding, and increased blood pressure particularly in hypertensive patients (van Laar, 2012).

  • Arthritis
  • Japan
  • United States
  • Pfizer Inc.
  • Roche Group

Crohn' s disease is an inflammatory bowel disease that causes inflammation in the digestive or gastrointestinal tract.

  • Arthritis
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Idec Inc.
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

Food and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee (GIDAC) meeting.

  • Arthritis
  • Therapy
  • United States
  • Product Initiative
  • Pfizer Inc.
  • BARICITINIB - DRUG PROFILE

THERE WERE NO CASES OF GASTROINTESTINAL PERFORATIONS.

  • Arthritis
  • Hospital
  • United States
  • Product Initiative
  • Incyte Corporation

SR One Ltd.

  • Arthritis
  • Pharmaceutical
  • United States
  • Company Financials
  • Regeneron Pharmaceuticals, Inc.

On July ##, 2018, the product-specific Q code for ZILRETTA took effect.

  • Arthritis
  • Pharmaceutical
  • Therapy
  • United States
  • Flexion Therapeutics, Inc.

It serves patients suffering from gastrointestinal and liver diseases.

  • Arthritis
  • Autoimmune Disease
  • United States
  • Company
  • Product Initiative
  • OSTEOARTHRITIS - PIPELINE BY K-STEMCELL CO LTD, H1 2018
  • OSTEOARTHRITIS - PIPELINE BY INTERNATIONAL STEM CELL CORP, H1 2018

The company offers APIs in the therapeutic areas of antibiotic, oncology, cardiovascular, urology, gastrointestinal, antiviral and respiratory, among others.

  • Arthritis
  • Cell Therapy
  • United States
  • Product Initiative
  • Amgen Inc.
  • FEB 01, 2017: MIV-711 OSTEOARTHRITIS TRIAL: SUCCESSFUL FOURTH INDEPENDENT REVIEW OF SAFETY DATA ENABLES TRIAL CONTINUATION WITHOUT ANY MODIFICATIONS
  • Cathepsin K (Cathepsin O or Cathepsin O2 or Cathepsin X or CTSK or EC 3.4.22.38) - Product Development Milestones

The molecules developed by companies in Phase II, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Arthritis
  • United States
  • World
  • Product Initiative
  • Medivir UK Ltd.
  • SMALL MOLECULES TO INHIBIT RIP2 FOR POLYARTHRITIS, GASTROINTESTINAL DISORDERS AND RHEUMATOID ARTHRITIS - DRUG PROFILE

Crohn’s Disease (Regional Enteritis) - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Crohn’s Disease (Regional Enteritis) - Pipeline Review, H1 2018, provides an overview of the Crohn’s Disease (Regional Enteritis) (Gastrointestinal)...

  • Arthritis
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative

Q. ##.

  • Arthritis
  • North America
  • United States
  • Forecast
  • Thermo Fisher Scientific, Inc.
  • SMALL MOLECULES TO INHIBIT RIP2 FOR POLYARTHRITIS, GASTROINTESTINAL DISORDERS AND RHEUMATOID ARTHRITIS - DRUG PROFILE
  • RHEUMATOID ARTHRITIS - PIPELINE BY ONCODESIGN SA, H2 2017

Rheumatoid Arthritis - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H2 2017, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape. Rheumatoid arthritis...

  • Arthritis
  • Pathology
  • Therapy
  • United States
  • Pfizer Inc.
  • DIMETHYL FUMARATE DR - DRUG PROFILE
  • DIMETHYL FUMARATE DR - DRUG PROFILE

Key GI symptoms, including nausea, vomiting, upper and lower abdominal pain and diarrhea, will be assessed using two patient-reported symptom rating scales: the Individual Gastrointestinal Symptom and Impact Scale (IGISIS) and the Global Gastrointestinal Symptom and Impact Scale (G

  • Arthritis
  • Cell Therapy
  • Neurological Disorder
  • Respiratory Monitoring
  • Anavex Life Sciences Corp.

Subjects will be allocated to each treatment sequence in a ##:## ratio.

  • Arthritis
  • Pain Relief
  • Research And Development
  • Therapy
  • Flex Pharma, Inc.

It targets JAK ##.

  • Arthritis
  • Digestive System Disorder
  • Company
  • Product Initiative
  • Galapagos NV

In July 2015, La Jolla Pharmaceutical Company received an orphan designation from US Food and Drug Administration (FDA) for ##-(##-(##, ##-Napthrydine)-Imidazole [##, ##-a] pyridine-##-(##-phenyl-##-(##-(##methyl piperazine) for the treatment of fibrodysplasia ossificans pro

  • Arthritis
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • ANTISENSE RNAI OLIGONUCLEOTIDE FOR ARTHRITIS AND GASTROINTESTINAL DISORDERS - DRUG PROFILE

Inflammatory Bowel Disease - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Inflammatory Bowel Disease - Pipeline Review, H2 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Inflammatory...

  • Arthritis
  • Autoimmune Disease
  • Research And Development
  • Therapy
  • Pfizer Inc.
  • DIMETHYL FUMARATE DR - DRUG PROFILE
  • CD-24FC - DRUG PROFILE

Key GI symptoms, including nausea, vomiting, upper and lower abdominal pain and diarrhea, will be assessed using two patient-reported symptom rating scales: the Individual Gastrointestinal Symptom and Impact Scale (IGISIS) and the Global Gastrointestinal Symptom and Impact Scale (G

  • Arthritis
  • Cell Therapy
  • Respiratory Monitoring
  • United States
  • Anavex Life Sciences Corp.

One unit is one oximeter sensor.

  • Respiratory Monitoring
  • Sensor
  • United States
  • Company
  • GlobalData's company